A Japanese research team has discovered a novel global cooperative phenomena of cell interactions in cervical cancer cells. Their findings suggest that the cells are metabolically connected in a ...

Evaxion will present new biomarker and immune data obtained from the ongoing phase 2 trial. These will further add to EVX-01’s already strong clinical data package.

Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies ...

Since then, a global systematic review of 63 studies from 2024, commissioned by the World Health Organization, also indicated ...

For organs to develop, grow and regenerate, cells must proliferate. But when that process goes awry, leading to uncontrolled cell growth, cancer can emerge.

The unexpected discovery may provide scientists with new insights into how cancer develops — and how to combat it.

Mutant KRAS in ctDNA in patients with localized pancreatic cancer was shown to be a biomarker for metastatic progression and ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in ...

Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.